Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

AbbVie Inc (ABBV)

Index:

S&P 100

Add To Portfolio

$ 185.30

Change Today:

$-0.19
52 Week High: $216.66
52 Week Low: $163.84

Currency: US Dollars
Shares Issued: 1,765.26m
Volume: 12,158,103

Market Cap: $327,102m
RiskGrade: 122
Beta: 0.44

Latest ShareCast News

AstraZeneca sells hypertension drug rights; Ends Allergan deal

By Frank Prenesti

Date: Monday 27 Jan 2020

(Sharecast News) - AstraZeneca said it had agreed to sell the global commercial rights to a range of hypertension treatments to Atnahs Pharma for up to $390m.

Read full story

News Channel

AbbVie Inc ShareCast News

Botox maker Allergan reports jump in third-quart...	05-Nov-2019	ShareCast
Abbvie snaps up Botox-maker Allergan in $63bn deal	25-Jun-2019	ShareCast
Pharma firms to testify in Congress over drug pr...	26-Feb-2019	ShareCast

More AbbVie Inc ShareCast news

AbbVie Inc Newspaper Links

Abbvie boss blasts US tax regime	21-Oct-2014	Telegraph
Drug company AbbVie takeover rival in £31bn bid	18-Jul-2014	Express & Star
AbbVie to announce firm bid for Shire	18-Jul-2014	Telegraph
AbbVie's raised proposal for Shire gets board ba...	15-Jul-2014	Guardian
Shire set to accept £31bn bid from US rival AbbVie	15-Jul-2014	Express & Star

More abbvie inc newspaper links

AbbVie Inc Tips & Analysis

No recent information was found.

AbbVie Inc News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

AbbVie Inc Market Data

Currency	US Dollars
Share Price	$ 185.30
Change Today	$ -0.19
% Change	-0.10 %
52 Week High	$216.66
52 Week Low	$163.84
Volume	12,158,103
Shares Issued	1,765.26m
Market Cap	$327,102m
Beta	0.44
RiskGrade	122